ANDA 74703, held by Pharmobedient Cnsltg. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 74703 (Metoclopramide Hydrochloride), held by Pharmobedient Cnsltg, was first approved by FDA on Oct 31, 1997, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/5ML · solution;oral | Metoclopramide Hydrochloride | Discontinued |
| Apr 8, 2014 | Supplement 10Labeling | Approved | None posted |
| May 16, 2012 | Supplement 5Labeling | Approved | None posted |
| Feb 17, 2011 | Supplement 8Labeling | Approved | None posted |
| Feb 15, 2011 | Supplement 9Labeling | Approved | |
| Sep 15, 2009 | Supplement 7Labeling | Approved | |
| Jun 30, 2009 | Supplement 6Labeling | Approved | |
| Aug 18, 2003 | Supplement 4Labeling | Approved | None posted |
| Jul 12, 2002 | Supplement 3Labeling | Approved | None posted |
| Dec 20, 2001 | Supplement 2Labeling | Approved | None posted |
| Sep 21, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Oct 31, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters